日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment.

基线 CXCL9 水平低可预测接受 Atezolizumab 联合 Bevacizumab 治疗的不可切除 HCC 患者的早期疾病进展

期刊:Liver Cancer
影响因子:9.1
doi:10.1159/000527759
Hosoda Shunichi, Suda Goki, Sho Takuya, Ogawa Koji, Kimura Megumi, Yang Zijian, Yoshida Sonoe, Kubo Akinori, Tokuchi Yoshimasa, Kitagataya Takashi, Maehara Osamu, Ohnishi Shunsuke, Nakamura Akihisa, Yamada Ren, Ohara Masatsugu, Kawagishi Naoki, Natsuizaka Mitsuteru, Nakai Masato, Morikawa Kenichi, Furuya Ken, Baba Masaru, Yamamoto Yoshiya, Suzuki Kazuharu, Izumi Takaaki, Meguro Takashi, Terashita Katsumi, Ito Jun, Miyagishima Takuto, Sakamoto Naoya
其它
发表日期：2023
文献求助 收藏

Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma.

乐伐替尼治疗期间血清生长因子的变化可预测不可切除肝细胞癌患者的进展后生存期

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14010232
Yang Zijian, Suda Goki, Maehara Osamu, Ohara Masatsugu, Yoshida Sonoe, Hosoda Shunichi, Kimura Megumi, Kubo Akinori, Tokuchi Yoshimasa, Fu Qingjie, Yamada Ren, Kitagataya Takashi, Suzuki Kazuharu, Kawagishi Naoki, Nakai Masato, Sho Takuya, Natsuizaka Mitsuteru, Morikawa Kenichi, Ogawa Koji, Ohnishi Shunsuke, Sakamoto Naoya
细胞生物学
肿瘤免疫
发表日期：2022
文献求助 收藏

Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy

血清IL-1β水平可预测丙型肝炎直接抗病毒治疗期间乙型肝炎病毒的新生再激活，但不能预测抗癌/免疫抑制治疗期间的乙型肝炎病毒再激活。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-022-21315-z
Kawagishi, Naoki; Suda, Goki; Sakamori, Ryotaro; Matsui, Takeshi; Onozawa, Masahiro; Yang, Zijian; Yoshida, Sonoe; Ohara, Masatsugu; Kimura, Megumi; Kubo, Akinori; Maehara, Osamu; Fu, Qingjie; Hosoda, Shunichi; Tokuchi, Yoshimasa; Suzuki, Kazuharu; Nakai, Masato; Sho, Takuya; Morikawa, Kenichi; Natsuizaka, Mitsuteru; Ogawa, Koji; Sakai, Hajime; Ohnishi, Shunsuke; Baba, Masaru; Takehara, Tetsuo; Sakamoto, Naoya
肿瘤
肿瘤免疫
微生物学
IL-1β
肝炎
免疫/内分泌
发表日期：2022
文献求助 收藏

Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication

利用丙型肝炎病毒根除后瞬时弹性成像的年龄和肝脏硬度预测肝细胞癌

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-022-05492-5
Nakai, Masato; Yamamoto, Yoshiya; Baba, Masaru; Suda, Goki; Kubo, Akinori; Tokuchi, Yoshimasa; Kitagataya, Takashi; Yamada, Ren; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Sho, Takuya; Morikawa, Kenichi; Ogawa, Koji; Furuya, Ken; Sakamoto, Naoya
肿瘤
肿瘤免疫
微生物学
细胞生物学
肝炎
发表日期：2022
文献求助 收藏

Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on lipid profiles in patients with hepatitis B

替诺福韦酯富马酸酯换用替诺福韦艾拉酚胺对乙型肝炎患者血脂谱的影响

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0261760
Suzuki, Kazuharu; Suda, Goki; Yamamoto, Yoshiya; Abiko, Satoshi; Kinoshita, Kenji; Miyamoto, Shuichi; Sugiura, Ryo; Kimura, Megumi; Maehara, Osamu; Yamada, Ren; Kitagataya, Takashi; Shigesawa, Taku; Ohara, Masatsugu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, Naoya
肝炎
发表日期：2022
文献求助 收藏

Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients

利福昔明治疗日本患者隐匿性肝性脑病和高氨血症的疗效

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0270786
Nakai, Masato; Suda, Goki; Ogawa, Koji; Yoshida, Sonoe; Hosoda, Shunichi; Kubo, Akinori; Tokuchi, Yoshimasa; Kitagataya, Takashi; Yamada, Ren; Shigesawa, Taku; Ohara, Masatsugu; Sho, Takuya; Morikawa, Kenichi; Sakamoto, Naoya
神经科学
发表日期：2022
文献求助 收藏

Pre-sarcopenia and Mac-2 binding protein glycosylation isomer as predictors of recurrence and prognosis of early-stage hepatocellular carcinoma

肌少症前期和Mac-2结合蛋白糖基化异构体作为早期肝细胞癌复发和预后的预测因子

期刊:World Journal of Hepatology
影响因子:2.5
doi:10.4254/wjh.v14.i7.1480
Nakai, Masato; Morikawa, Kenichi; Hosoda, Shunichi; Yoshida, Sonoe; Kubo, Akinori; Tokuchi, Yoshimasa; Kitagataya, Takashi; Yamada, Ren; Ohara, Masatsugu; Sho, Takuya; Suda, Goki; Ogawa, Koji; Sakamoto, Naoya
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Frequency and Characteristics of Overestimated Renal Function in Japanese Patients with Chronic Liver Disease and Its Relation to Sarcopenia

日本慢性肝病患者肾功能高估的发生率和特征及其与肌少症的关系

期刊:Nutrients
影响因子:5
doi:10.3390/nu13072415
Yoshida, Sonoe; Suda, Goki; Ohara, Masatsugu; Fu, Qingjie; Yang, Zijian; Hosoda, Shunichi; Kimura, Megumi; Akinori, Kubo; Tokuchi, Yoshimasa; Yamada, Ren; Kitagataya, Takashi; Suzuki, Kazuharu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Maehara, Osamu; Ohnishi, Shunsuke; Sakamoto, Naoya
发表日期：2021
文献求助 收藏

Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI

EOB-MRI肝胆期呈等高信号的不可切除肝细胞癌的特征及乐伐替尼治疗反应

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers13143633
Kubo, Akinori; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Tokuchi, Yoshimasa; Kitagataya, Takashi; Ohara, Masatsugu; Yamada, Ren; Shigesawa, Taku; Suzuki, Kazuharu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Ohnishi, Shunsuke; Sakamoto, Naoya
信号转导
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Possible correlation between increased serum free carnitine levels and increased skeletal muscle mass following HCV eradication by direct acting antivirals

直接抗病毒药物根除丙型肝炎病毒后，血清游离肉碱水平升高与骨骼肌质量增加之间可能存在相关性

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-021-96203-z
Tokuchi, Yoshimasa; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Kitagataya, Takashi; Kubo, Akinori; Yoshida, Sonoe; Fu, Qingjie; Yang, Zijian; Hosoda, Shunichi; Ohara, Masatsugu; Yamada, Ren; Suzuki, Kazuharu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Ohnishi, Shunsuke; Sakamoto, Naoya
微生物学
肝炎
发表日期：2021
文献求助 收藏